04/23/2026
The common dandelion, a plant found in gardens and fields worldwide, contains bioactive compounds that researchers are studying for their potential role in supporting the body's defenses against cancer cell growth, according to a comprehensive scientific review published in the journal Nutrients. Laboratory studies summarized in the review found that compounds extracted from dandelion roots, leaves, and seeds were able to interfere with multiple biological processes that cancer cells rely on to grow and spread, including disrupting cell division cycles, triggering self-destruction in cancer cells, and limiting their ability to migrate to other tissues. The compounds showing the most consistent results in laboratory settings were called taraxasterol and polysaccharides, and they showed activity against breast, liver, lung, gastric, and colorectal cancer cells in experimental models. Importantly, researchers note these compounds showed no toxicity toward normal healthy cells in the studies reviewed. This is a laboratory and animal research review and the compounds have not yet been tested in large-scale human clinical trials, meaning they are not an established cancer treatment and should not replace any medical care. Scientists say the goal is to explore dandelion compounds as potential sources for future drug development. Did you know that the plants growing in your garden may be subjects of serious scientific research around the world?
Shared for information purposes only.
Source: Nutrients..Doi. org/10.3390/nu17233769